Presentations to View

These presentations can be downloaded and used for information, but are in a read-only format (PDF). The viewer, Adobe Acrobat Reader is freely available.

To view in a browser with the Acrobat Reader Plug-in, click on the links below. These are large files and make take some time to view. To download, hold down the shift key while clicking the link. *

"Vitamin D Controversies"

By By Dr. Ross Morton MD FRCP FRCPC, Kingston General Hospital, Kingston ON, .
Presented March 28th, 2008 at the Renal Pharmacists Network Nephrology Education Day

Only logged in Web Account holders can download files.

"Diabetes Management in CKD"

By By Anar Dossa BScPharm CDE, Vancouver General Hospital, Vancouver BC, .
Presented March 28th, 2008 at the Renal Pharmacists Network Nephrology Education Day

Only logged in Web Account holders can download files.

"Hemodialysis catheter-related infections and the use of antibiotic/anticoagulant locks: an update"

By By Dr. Lavern Vercaigne BSc. (Pharm) Pharm D. Winnipeg MB, .
Presented March 28th, 2008 at the Renal Pharmacists Network Nephrology Education Day

Only logged in Web Account holders can download files.

"Renal Failure in the Non-Renal Transplant Patient: Beyond the Kidney"

By By Jennifer Harrison, BScPhm, MSc University Health Network Toronto, ON, .
Presented March 28th, 2008 at the Renal Pharmacists Network Nephrology Education Day

Only logged in Web Account holders can download files.

"Is Nocturnal Hemodialysis the answer to the poor outcomes in ESRD?"

By Dr. Christopher Chan MD FRCPC, University health network, Toronto Ontario.
Presented October 18th , 2007 at the Renal Pharmacist Network, Educational Evening

Learning Objectives:
1. To update research in progress in the field of nocturnal home hemodialysis
2. To describe the available clinical experience of nocturnal home hemodialysis
3. To discuss potential future clinical and research direction of nocturnal home hemodialysis

Only logged in Web Account holders can download files.

"Statins, Cholesterol and Chronic Kidney Disease - CANNT 2005"

By Jenny Ng, BScPhm, Sunnybrook and Women's College Health Sciences Centre (Toronto, ON).
October 15th, 2005 at CAANT (in partnership with RPN) national conference

A review of dyslipidemia in the chronic renal failure patient through to examination of current management guidelines and research in the use of statins for reduction in CV mortality.

Only logged in Web Account holders can download files.

"The Latest on Antibiotic Lock Therapy for Prevention and Treatment of Hemodialysis Catheter Infections"

By Lori Wazny, BScPhm, PharmD, Pharmaceutical Care Coordinator, Manitoba Renal Program (Winnipeg, MB).
Nov 19, 2004, at CANNT 2004 (in partnership with RPN) national conference, Niagara Falls, ON

The use of antibiotic locks in the prevention and adjunctive therapy of infections involving dialysis catheters is gaining popularity. This talk reviews this new treatment dtrategy and discusses antibiotic lock combinations with either citrate or heparin.

Only logged in Web Account holders can download files.

"Continuum of Care in Diabetic Nephropathy"

By Lori MacCallum BScPhm, PharmD, Clinical Pharmacy Specialist, Diabetes Comprehensive Care Program, St. Michael's Hospital, (Toronto, ON).
Nov 19, 2004, at CANNT 2004 (in partnership with RPN) national conference, Niagara Falls, ON

Diabetes is the leading cause of renal disease in North America. This presentation reviews the 2003 Canadian Diabetes Association clinical practice guidelines in the management of patients with diabetic nephropathy. Considerations for optimal use of pharmacological therapies at varying stages of chronic kidney disease are discussed.

Only logged in Web Account holders can download files.

"Pain Management in the Chronic Renal Failure Patient"

By Andrea Fox, BScPh and Jennifer Innis, Pharmacist and ACNP, Clinical Nurse Practitioner; St. Michael's Hospital (Toronto, ON).
Nov 19, 2004, at CANNT 2004 (in partnership with RPN) national conference, Niagara Falls, ON

This presentation reviews pain assessment from a nurse practitioner's perspective coupled with a pharmacist's assessment of treatment alternatives in the chronic renal failure patient.

Only logged in Web Account holders can download files.

"MDRD to Assess Renal Function: How Does It Compare?"

By Karen Shalansky, Pharm D, Pharmacotherapeutic Specialist, Nephrology; Vancouver General Hospital (Vancouver, BC).
Presented on Nov 20, 2004, at CANNT 2004 (in partnership with RPN) national conference, Niagara Falls, ON

A review of various mehods to assess creatinine clearance including the new MDRD method recently adopted in British Columbia.

Only logged in Web Account holders can download files.

"'Stop Cracking:' Vitamin D Analogues and Phosphate Binders"

By Jennifer Brick, BScPhm (Zemplar);Jenny Ng, BScPhm ( Hecterol); Lisa Sever, BScPhm (Lanthanum), Grand River Hospital (Kitchener, ON); Sunnybrook and Women's College Health Sciences Centre (Toronto, ON); York Central Hospital (Richmond Hill, ON).
Presented on Nov 20, 2004, at CANNT 2004 (in partnership with RPN) national conference, Niagara Falls, ON

A review of the newest agents in renal bone disease.

Only logged in Web Account holders can download files.

"Complete Switch to Darbepoetin"

By Karen Shalansky, Pharm D, Pharmacotherapeutic Specialist, Nephrology; Vancouver General Hospital (Vancouver, BC).
Presented on Nov 20, 2004, at CANNT 2004 (in partnership with RPN) national conference, Niagara Falls, ON

A review of the trial that began March 2003 at Vancouver General Hospital studying the switch from SC Erythropoetin to IV Darbepoetin. Study objectives were 1) to assess the ability of Nesp (Aranesp) to maintain target Hemoglobins; 2) determine an appropriate dose conversion from Epo (Eprex) to Nesp (Aranesp); and 3) to perform a cost analysis. Study followed patients 6 months prior to switch and evaluated at 12 months post switch.

Only logged in Web Account holders can download files.

"Medication Review Utilizing a Computer Generated Patient Friendly Medication Schdule for Hemodialysis Patients"

By Jenny Ng, BScPhm, Sunnybrook and Women's College Health Sciences Centre (Toronto, ON).
Presented on Nov 20, 2004, at CANNT 2004 (in partnership with RPN) national conference, Niagara Falls, ON

Results of a pilot project utilizing a patient friendly medication schedule for Hemodialysis patients to review medications; assess patient's degree of satisfaction with it.

Only logged in Web Account holders can download files.

"Multidisciplinary Approach to EPO Resistance in a Hemodialysis Unit"

By Karen Shalansky, PharmD, .
presentated on November 1, 2003, at CANNT Symposium 2003, Vancouver, BC

Only logged in Web Account holders can download files.

"tPA Instillation: Pulse Instillation vs. Extended Dwell"

By Joanne Jung, BSc (Pharm), .
presentated on November 1, 2003, at CANNT Symposium 2003, Vancouver, BC

Only logged in Web Account holders can download files.

"Hypocalcemia Management post-Parathyroidectomy: Case Study"

By Brenda Bruinooge, BSc (Pharm), Nephrology Pharmacist, Richmond Hill, ON.
presentated on October 31, 2003, at CANNT Symposium 2003, Vancouver, BC

After reviewing the pathophysiology of mineral shifts post-parathyroidectomy, you will participate in a review of cases of patients who have undergone a parathyroidectomy, and learn management strategies and clinical pearls of treatment of hypocalcemia in hemodialysis patients.

Only logged in Web Account holders can download files.

"Glycemic management in Patients with Chronic Kidney Disease"

By Piera Calissi, PharmD, Clinical Coordinator, Pharmacy Services, St. Paul?s Hospital, Saskatoon.
presentated on October 31, 2003, at CANNT Symposium 2003, Vancouver, BC

This talk with review the pathogenesis, assessment and treatment of hyperglycemia in diabetics with chronic kidney disease.

Only logged in Web Account holders can download files.

"Enhancing Diabetes Care in the Dialysis Patient"

By Maryann Hopkins, BSP, Clinical Pharmacist, Diabetes Education Program, Ottawa Hospital .
presentated on October 31, 2003, at CANNT Symposium 2003, Vancouver, BC

This presentation will briefly review diabetic nephropathy and challenges the diabetic patients on dialysis experience. The presentation will also discuss actual cases and the interventions performed that helped improve both diabetes management and their quality of life.

Only logged in Web Account holders can download files.

"Calcium and Phosphorus Disruption in Chronic Kidney Disease"

By Lori MacCallum, PharmD, Clinical Pharmacy Specialist, Diabetes Comprehensive Care Program, St. Michael's Hospital.
presentated on October 31, 2003, at CANNT Symposium 2003, Vancouver, BC

Disruption in calcium and phosphorus balance is a common complication in people with chronic kidney disease and often results in devastating outcomes. This presentation will address the clinical consequences of calcium/phosphorus balance, and review monitoring parameters, treatment options and treatment goals that will help improve clinical outcomes in people chronic kidney disease.

Only logged in Web Account holders can download files.

"The Role of Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the CRI Clinic Population"

By Jennifer Dykeman-Sharpe, BScPharm, Clinical Coordinator, Pharmacy Services, Atlantic Health Services Corporation.
presentated on October 31, 2003, at CANNT Symposium 2003, Vancouver, BC

The use of ACEI's and ARBs inpatients with minimal GFR is controversial and a delicate balance of risk vs. benefit. This talk will review the current evidence and offer some guidance for using and monitoring of these therapies in this population.

Only logged in Web Account holders can download files.

"Immunosuppression in Transplantation: Current and Future Trends"

By Nilufar Partovi, PharmD, Pharmacotherapeutic Specialist, Solid Organ Transplant, Vancouver General Hospital.
presentated on October 31, 2003, at CANNT Symposium 2003, Vancouver, BC

Immunosuppression for prevention of solid organ rejection is a continually evolving field. This talk will focus on current strategies of immunosuppression and future trends.

Only logged in Web Account holders can download files.

"Herbal Drug Use in Renal Failure"

By Anar Dossa, BScPharm, Certified Diabetes Educator, Staff Development Coordinator, Vancouver General Hospital.
presentated on October 31, 2003, at CANNT Symposium 2003, Vancouver, BC

Focuses on the safety and efficacy of common herbal products used by patients in the renal clinic

Only logged in Web Account holders can download files.

"Management of Thrombosis in Hemodialysis Catheters"

By Lavern Vercaigne, PharmD, Associate Professor, Faculty of Pharmacy, University of Manitoba.
presentated on October 31, 2003, at CANNT Symposium 2003, Vancouver, BC

Only logged in Web Account holders can download files.

"Drug Dosing In Ambulatory Pertineal Dialysis"

By George R. Bailie, PharmD, PhD, Professor, Albany College of Pharmacy, Director, Nephrology Pharmacy Associates.
presentated on September 11, 2003, to the Renal Pharmacists Network, Toronto, ON

Dr. Bailie gave a brief history of the empiric treatment of peritonitis in ambulatory peritoneal dialysis patients. He included a discussion of the risks and cautions of resistance, pharmacokinetics, efficacy and current dosing recommendations for cefazolin, tobramycin, piperacillin and vancomycin. This was a very good overview which will benefit all renal staff involved in treating infections in their CAPD patients.

Only logged in Web Account holders can download files.

"Immunological Factors in Renal Disease"

By Dr. Gerald Rosenstein, Grand River Hospital.
presented on September 12, 2002 at the Quarterly Education Session, Holiday Inn, Toronto.

Dr. Rosenstein gave a thorough overview of many different immunological factors causing kidney failure. This was broken down into clinical presentation & course, differential diagnosis and treatment strategies.

Mechanism of action of drug treatment was also reviewed briefly. This presentation would be of interest to any pharmacist in the renal area.

Only logged in Web Account holders can download files.

"NSAID's and the Kidney: Safe or Not?"

By Dr. David Mendelssohn, Scarborough General Hospital.
Presented December 11, 2001 at the Quarterly Educational Session, Holiday Inn, Toronto.

Dr. Mendelssohn reviewed the literature on the use of COX-2 inhibitors and patients with renal diesease. He reviewed the current recommendations for blood pressure control and the challenges to reaching these targets. Since the use of COX-2's might affect blood pressure, these were reviewed with respect to blood pressure control and other cardiac outcomes.

Only logged in Web Account holders can download files.

"Homocystein: An Emerging marker for cardiovascular disease in dialysis patients"

By Dr. Robert Ting, Scarborough General Hospital.
Presented September 13, 2001, at the quarterly Education session

An overview of the metabolism of homocysteine, the causes of high homocysteine, the risks for cardiovascular events if homocysteine is elevated as well as treatment options.

Only logged in Web Account holders can download files.

"Renal Bone Disease"

By Sean Albanese <albaness@tbh.net>, Renal Service Pharmacist, Thunder Bay Regional Hospital.
Presented May 26, 2001

Presentation at the 4th annual Contemporary Therapeutic Issues in Cardiology and Nephrology held at Hotel Intercontinental in Toronto, ON.

Only logged in Web Account holders can download files.

"Hyperhomocysteinemia: The Folic Acid Controversy"

By Brenda Bruinooge <bbruinooge@yorkcentral.on.ca>, B.Sc.Phm., Nephrology Pharmacist, York Region Dialysis Program, York Central Hospital, Richmond Hill, Ontario.
Presented May 17,2001, at the quarterly Education session at Howard Johnson's (Yorkdale), Toronto, ON

This presentation was a review of the latest literature on Homocysteine in Renal failure and the role of Folic Acid in improving Cardiovascular outcomes. In essence, it was noted that 1mg per day (found in Replavite) is no better than 5mg except in the Prerenal (PRI) or transplant population, and even that data suggests that 1mg will lower homocysteine levels to almost normal levels. Current studies have looked at homocysteine and its correlation with improvment in endothelial wall function. Also included are references the end of the presentation for those would like to get more information about this topic. She welcomes any discussion about the information found in these slides or questions about the topic in general.

Only logged in Web Account holders can download files.

"Pharmacokinetics & Pharmacoeconomics of Vitamin D Analogs"

By Lori D. Wazny <Lori.Wazny@lhsc.on.ca>, Pharm.D., Nephrology Clinical Specialist, Southwestern Ontario Regional Self Care Dialysis Centre.
Presented May 12, 2001

Lori Wasny presented information on Vitamin D preparations for the Renal population for the Leo Pharma (Inc) One-Alpha Advisory Board. In attendance were Nephrologists, Pharmacists and Leo personnel. Please feel free to view the information. If you have any questions you can email Lori.

Only logged in Web Account holders can download files.

"Replavite and Diavite"

By Brenda Bruinooge <bbruinooge@yorkcentral.on.ca>, B.Sc.Phm., Nephrology Pharmacist, York Region Dialysis Program, York Central Hospital, Richmond Hill, Ontario.
Presented Sept. 22, 2000, to the Renal Dieticians Group of the Greater Toronto Area.

A discussion of the differences between Replavite and Diavite, as well as the role of Folic Acid in renal failure patients with Cardiovascular disease. It was ended with an introduction to the New Phosphate binder, Renagel (Sevalamer). This renal dieticans Eduicational day included talks by other dieticians and physicians. It was held in Richmond Hill, ON.

Only logged in Web Account holders can download files.